Akiva Felt News Today : Breaking News, Live Updates & Top Stories | Vimarsana

In a report published Friday, Oppenheimer analyst Akiva Felt initiated coverage of Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) with an Outperform rating and a price target of $18.
Analyst Akiva Felt believes that Tonix has been overlooked by investors after mixed Phase 2. Read More.
Don t Miss Any Updates!
News Directly in Your Inbox
Subscribe to: ....

Tonix Pharmaceuticalssunday , Elemer Piros , Tonix Pharma , Natalie Fertig , Zynerba Pharmaceuticals Inc , Cantor Fitzgerald , Tonix Pharmaceuticals Holding Corp , Penny Stocks , Pharma Fibromyalgia Treatment Associated , Pharmaceuticals Holding Corp , Cannabis Fibromyalgia , Fresh Toast , May Treat Fibromyalgia Pain , According To New Studyfriday , What Happened Tonix , Analyst Color , Long Ideas , Time To Buy Tonix Pharmaceuticalssunday , Akiva Felt , Tonix Pharmaceuticals Holding , Analyst Akiva Felt , நடாலி ஃபெர்டிக் , கேன்டர் ஃபிட்ஸ்‌ஜெரல்ட் , பைசா ஸ்டாக்ஸ் , மருந்துகள் வைத்திருத்தல் கார்ப் , புதியது சிற்றுண்டி ,